<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001635'>Heart failure</z:hpo> is a very common disease, with severe morbidity and mortality, and a frequent reason of hospitalization </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001903'>Anemia</z:hpo> and a concurrent <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> are two major risk factors contributing to the severity of the outcome and consist of the cardio renal <z:hpo ids='HP_0001903'>anemia</z:hpo> syndrome </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001903'>Anemia</z:hpo> in <z:hpo ids='HP_0001635'>heart failure</z:hpo> is complex and multifactorial </plain></SENT>
<SENT sid="3" pm="."><plain>Hemodilution, absolute or functional <z:e sem="disease" ids="C0240066" disease_type="Disease or Syndrome" abbrv="">iron deficiency</z:e>, activation of the inflammatory cascade, and impaired erythropoietin production and activity are some pathophysiological mechanisms involved in <z:hpo ids='HP_0001903'>anemia</z:hpo> of the <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore other concomitant causes of <z:hpo ids='HP_0001903'>anemia</z:hpo>, such as <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and chemotherapy, may worsen the outcome </plain></SENT>
<SENT sid="5" pm="."><plain>Based on the pathophysiology of cardiac <z:hpo ids='HP_0001903'>anemia</z:hpo>, there are several therapeutic options that may improve <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> levels, tissues' oxygenation, and probably the outcome </plain></SENT>
<SENT sid="6" pm="."><plain>These include administration of iron, erythropoiesis-stimulating agents, and blood transfusions but still the evidence provided for their use remains limited </plain></SENT>
</text></document>